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“Genes and Genetics in Hypertension and Vascular Disease” was
the theme of the International Society of Nephrology’s recent
Forefronts in Nephrology meeting in Grob Do¨lln, outside of
Berlin. The aim of the Forefronts series is to present the
state-of-the-art in different aspects of nephrology, which includes
the unresolved and current problems in the field. In that way,
active investigators, particularly our younger colleagues, can be
exposed to the current, often vexing problems of a particular
arena of study. This symposium on “Genes and Genetics of
Hypertension” was broad in scope and encompassed four major
areas highly relevant to vascular disease: (1) complex genetic
diseases; (2) animal models; (3) gene targeting; and (4) the
genetics of hypertension, diabetes, and obesity in humans. Fur-
thermore, young investigators were given the opportunity to
present posters on their most recent work and received criticism
and praise as the material dictated. All this occurred in an
environment of dense forest, a sparkling lake, ample physical
exercise, and pleasant evenings with wine and song.
Complex genetics encompasses complicated mathematics.
From the contribution of Francoise Clerget-Darpoux, the current
diverse strategies were presented. The merits and demerits of
linkage and association studies were argued by Hywel Jones and
Thomas Wienker. Evaluation of candidate genes and the identi-
fication of disease susceptibility loci by means of association
studies was critically appraised by linkage experts who instead
favor the noncommittal approach of a total genome scan to find
loci linked to a phenotype. The latter requires approximately 700
affected sibling pairs in the case of hypertension. Furthermore,
since hypertension arises in adulthood, and often later adulthood,
the likelihood of obtaining samples from the parents of affected
persons is limited. Newer strategies, such as haplotype relative
risk approaches through the analysis of trios, siblings and one
parent, may offer alternatives to case-control association studies.
“Bioinformatics” is a formidable, almost teutonic, term. What
does it mean and what are we to do with it? A round table was
used to introduce the audience to the topic. Jens Reich and Andre´
Reis lead the audience through the jungle of the genetics infor-
mation highway. Access to databases, living with “Blast,” ESTs,
where to go when you are cloning positionally, and how to survive
exon trapping, were some of the topics discussed.
The practical aspects of recruitment were presented by Herbert
Schuster, who has developed a program in which index patients
recruit their family members. Mailers with questionnaires and
EDTA blood tubes are sent, the family physicians are included in
the process, and confidentiality is assured. With this method,
Herbert has recruited about 1000 families with lipid disturbances.
The cover of this issue of Kidney International features an output
from Herbert’s oligonucleotide ligation assay (OLA) for the
diagnosis of familial hypercholesterolemia. This test permits the
simultaneous detection of many (200 if necessary) gene muta-
tions. A multicolor gel file shows primary data from one OLA
experiment with DNA from 16 individuals. Every band represents
a ligation product of a particular allele. Ligation products from
mutant alleles are easily detected as extra bands. A genotyper
software program analyzes the pattern of bands and produces a
standard data file reporting “positive” results of the test to the
investigator.
Andreas Busjahn presented twin studies that permit heritability
estimates by comparing intrapair variability between monozygotic
and dizygotic twins, and then a modified sibling pair analysis in
dizygotic twins to identify quantitative trait loci. With this tech-
nique, he has shown linkage between the IGF-1 gene locus, blood
pressure, and heart size.
“What to do with the samples” is an area moving at a ferocious
pace. Margret Hoehe presented multiplex sequencing, with which
she can sequence genes or gene segments highly efficiently in
large numbers of subjects. As an example, she presented data
from the Bergen Hypertension Study, in which she sequenced the
entire b-adrenoceptor gene in 60 people. The results were reveal-
ing. Steve Lombardi presented the latest “high tech” approaches
being developed by industry to keep up the pace. Gooey gels are
likely to be replaced by chips and mass spectroscopy techniques.
The next session concentrated on animal models. Detlev Gan-
ten had already given an overview on transgenic rat models.
Andreas Schedl presented the possibilities offered by heterolo-
gous knock out models and cre-lox knock out models. He
provided tantalizing glimpses into the development of the kidney
and the role of Wilm’s tumor suppressor gene, WT1. Is hyperten-
sive nephrosclerosis influenced by genetic variance? Clinical
observations suggest that black Americans have a greater propen-
sity to develop hypertension-induced renal injury compared to
whites. Dahl salt-sensitive rats develop more renal injury than
spontaneously hypertensive rats (SHR). Ted Kurtz provided
compelling evidence to support this hypothesis. In SHR made
congenic for the brown Norway (BN) histocompatility locus, he
and his associates transplanted kidneys, such as BN kidneys
resided in an SHR, which retained its native kidney. The kidneys
were exposed to precisely the same environment. Guess which
kidney did better or worse? Alan Deng provided insight into the
Dahl salt-sensitive hypertensive rat. Quantitative trait loci were
unraveled and the roles of nitric oxide in this important hyper-
tensive model were elucidated. Yoram Yagil and Chana Yagil
have worked for years on the Sabra rat, a salt sensitive model
established by Drori Ben Ishay. This model is unique in that the
salt resistant strain is resistant to DOCA-salt hypertension, com-
pared to the salt sensitive strain. New gene loci responsible for this
phenomenon have been identified. Again, nitric oxide cropped up.
Another inbred strain was discussed by Pavel Hamet. Here we
need more data. The session was closed by John Hunter, who
presented studies on gene-manipulated mice (input).
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After a 10 kilometer run in and around the lake, the next day
began with a session on somatic gene transfer in cardiovascular
disease. Oliver Smithies elegantly showed that genes can be
“duplicated” or “triplicated,” etc., in the same animal to show a
gene dosage effect. The influence of renin-angiotensin system
genes on blood pressure and other attributes was exposed in a
“knock your socks off” fashion. The power of molecular biology
was never as obvious as in this presentation.
Peter Carmeliet, a wine expert from Belgium, concentrated on
the coagulation system and demonstrated how knock outs of
tissue factor illustrates the surprising importance of this and other
factors on vascular structure and their role in the repair of injured
vessels. Julie Chao and her husband Lee used somatic gene
transfer of the kallikrein gene to investigate the role of this
protein in blood pressure regulation.
Hermann Haller gave insight into antisense approaches in the
therapy of vascular disease. He demonstrated that certain protein
kinase C isoforms, notably PKC a, are important in mediating
glucose-induced and hypoxia-induced endothelial damage. Anti-
sense oligodinucleotides (ODN) can ameliorate these effects.
Most impressive were the data in a model of reperfusion injury.
Here, antisense directed against the intercellular adhesion mole-
cule (ICAM)-1 protected against reperfusion injury. Preliminary
animal data suggest that antisense therapy may be important in
transplantation medicine.
Next, the group moved to specific genetic challenges in humans.
Florent Soubrier has been the most active human geneticist
exploring the renin-angiotensin system. The insertion/deletion
angiotensin converting enzyme gene polymorphism, the angio-
tensinogen M235T substitution, and a polymorphims in the AT1
receptor gene have captivated his interest. Most puzzling is the
angiotensin converting enzyme insertion/deletion (ACE I/D)
polymorphism, which does not seem to influence blood pressure
per se, but nevertheless has a surprising influence on cardiovascu-
lar risk, heart size, stroke, diabetes, and the course of nephroscle-
rosis.
Giuseppe Bianchi presented the most elegant sequence of
events. His group has been the first to find a hypertension-relevant
gene in the rat and elucidated the function of that gene. Adducin
is a cytoskeletal protein that influences the function of the sodium
pump, and mutations in this gene affect sodium reabsorption. The
Milan rat led the way to elucidating salt sensitivity. Bianchi’s
group has now found a mutation in the human adducin gene. By
association and linkage techniques, they have implicated this
mutation in salt sensitive hypertension and to the response from
thiazide diuretics.
Wilhelm Weitz was the first to implicate genetics in hyperten-
sion over 80 years ago. Weitz performed case control, sibling pair,
and twin studies, and concluded that hypertension is a monogenic
disease. George Pickering proved that Weitz was wrong. But was
he? David Simon led us through a series of salt- and water-related
monogenic syndromes. Some, like glucocorticoid-remediable al-
dosteronism, Liddle’s syndrome, and the syndrome of apparent
mineralocorticoid excess, cause hypertension. Interestingly, alter-
native syndromes exist. For instance, Gitleman’s syndrome is
caused by a mutated Na/Cl distal tubular transporter, and Bart-
ter’s syndrome is caused by a defective Na2ClK transporter. These
conditions have given us amazing insight into salt and water
metabolism.
Sylvia Ba¨hring celebrated her birthday by telling us about a
monogenic syndrome not related to salt and water balance.
Autosomal-dominant hypertension and brachydactyly is an un-
usual condition described in Turkey, Canada, and the United
States. The hypertension is severe, causes stroke, and cosegre-
gates 100% with brachydactyly. Affected persons exhibit acceler-
ated fibroblast growth in culture, which has also been described in
essential hypertension and animal models. Sylvia showed differ-
ential display data and other functional cloning approaches.
Cloning this gene may give important insights into essential
hypertension.
The final discussion dealt with metabolic disorders. Graeme
Bell carried us back to southern Texas, Starr county to be exact. In
an affected sibling study, his group found an exciting gene locus
for type II diabetes mellitus on chromosome 3. (By the way,
Greame Bell and Matthias Ko¨hler were also the fastest partici-
pants in the 10K race, although Heini Murer received the
age-related runner’s prize. Friedrich Luft, unfortunately, fell off
the pace.) Kumar Sharma discussed obesity and the OB gene in
the pathogenesis of that condition. Interestingly, the OB gene has
specific relevance to decreased renal function and to patients
requiring dialysis treatments.
Whither from here? We believe that this Forefronts in Nephrol-
ogy topic could be held every two years and contain entirely new
information. Insights into genes and genetic studies are rapidly
unfolding from many directions because of new technology, cross
fertilization of ideas, and more specialized tools for scientific
discovery. Indeed, the future is now.
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